Linked Data API

Show Search Form

Search Results

1461042
registered interest false more like this
date less than 2022-05-10more like thismore than 2022-05-10
answering body
Department of Health and Social Care remove filter
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading National Institute for Health and Care Excellence remove filter
house id 2 more like this
legislature
25277
pref label House of Lords remove filter
question text To ask Her Majesty's Government whether they plan to publish the names of the organisations which took part in the early engagement programme with the National Institute for Health and Care Excellence before the publication of its new methods and processes for its health technology evaluation programme. more like this
tabling member printed
Lord Hunt of Kings Heath more like this
uin HL69 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2022-05-20more like thismore than 2022-05-20
answer text <p>While there was no specific early engagement programme, the National Institute for Health and Care Excellence’s (NICE) recent review of its methods and processes for health technology evaluation was overseen by a steering group and working group. The organisations which participated in these groups are as follows:</p><p>Centre for Health Technology Evaluation, NICE;</p><p>Centre for Guidelines, NICE;</p><p>Centre for Health Economics, University of York;</p><p>NHS England and NHS Improvement;</p><p>The Office for Life Sciences;</p><p>The Department of Health and Social Care;</p><p>NICE appraisal committee;</p><p>British In Vitro Diagnostics Association;</p><p>The Association of the British Pharmaceuticals Industry;</p><p>The Psoriasis and Psoriatic Arthritis Alliance;</p><p>The British Medical Journal Technology Assessment Group;</p><p>The Ethical Medicines Industry Group;</p><p>The BioIndustry Association;</p><p>Genetic Alliance;</p><p>ReCor Medical UK, Association of British HealthTech Industries;</p><p>School of Health and Related Research, the University of Sheffield;</p><p>Alzheimer's Research UK.</p>
answering member printed Lord Kamall more like this
question first answered
less than 2022-05-20T09:58:16.937Zmore like thismore than 2022-05-20T09:58:16.937Z
answering member
4909
label Biography information for Lord Kamall more like this
tabling member
2024
label Biography information for Lord Hunt of Kings Heath more like this
1461043
registered interest false more like this
date less than 2022-05-10more like thismore than 2022-05-10
answering body
Department of Health and Social Care remove filter
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading National Institute for Health and Care Excellence remove filter
house id 2 more like this
legislature
25277
pref label House of Lords remove filter
question text To ask Her Majesty's Government what work they are currently undertaking, if any, to identify topics which require modular updates by the National Institute for Health and Care Excellence and which may be facilitated for entry to managed access. more like this
tabling member printed
Lord Hunt of Kings Heath more like this
uin HL70 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2022-05-25more like thismore than 2022-05-25
answer text <p>The National Institute for Health and Care Excellence’s (NICE) outline for future modular updates was published in the January 2022 board paper Review of methods, processes and topic selection for health technology evaluation programmes: conclusions and final update. The paper states that NICE has identified potential topics for future modular reviews, including processes to facilitate rapid entry to managed access, methods issues for digital, genomic and antimicrobial technologies and the societal value of health benefits in severe diseases and health inequalities. A copy of the paper is attached. During the implementation of NICE’s strategy 2021 to 2026, it will prioritise developing a proportionate approach to health technology appraisals and MedTech early value assessment in the next 12 months.</p> more like this
answering member printed Lord Kamall more like this
question first answered
less than 2022-05-25T11:19:37.367Zmore like thismore than 2022-05-25T11:19:37.367Z
answering member
4909
label Biography information for Lord Kamall more like this
attachment
1
file name Review of methods, processes and topic selection for health technology evaluation programmes conclusions and final update (1).docx more like this
title NICE more like this
tabling member
2024
label Biography information for Lord Hunt of Kings Heath more like this
1124902
registered interest false more like this
date less than 2019-05-07more like thismore than 2019-05-07
answering body
Department of Health and Social Care remove filter
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading National Institute for Health and Care Excellence remove filter
house id 2 more like this
legislature
25277
pref label House of Lords remove filter
question text To ask Her Majesty's Government when they estimate that NICE will publish the outcome of the NICE Evaluation Committee meeting held on 6 March. more like this
tabling member printed
Baroness Thomas of Winchester more like this
uin HL15577 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2019-05-17more like thismore than 2019-05-17
answer text <p>Departmental officials are in regular contact with colleagues in the National Institute for Health and Care Excellence (NICE) and NHS England about a range of issues, including progress in discussions about a potential managed access agreement for Spinraza (nusinersen). Ministers have also held meetings with Biogen, NICE and NHS England on a number of occasions, at which the availability of Spinraza was discussed.</p><p>NHS England and NICE have made stakeholders and the public aware of the outcome of its appraisal committee meeting and NICE is now able to recommend the use of Spinraza for National Health Service patients in England, subject to a managed access agreement agreed between NHS England and Biogen. The final appraisal document will be published in due course.</p><p> </p> more like this
answering member printed Baroness Blackwood of North Oxford more like this
grouped question UIN HL15576 more like this
question first answered
less than 2019-05-17T11:07:46.673Zmore like thismore than 2019-05-17T11:07:46.673Z
answering member
4019
label Biography information for Baroness Blackwood of North Oxford more like this
tabling member
3785
label Biography information for Baroness Thomas of Winchester more like this